E3 PreliminaryPreliminaryPEM not requiredMechanisticPeer-reviewedMachine draft
Moxibustion upregulates hippocampal progranulin expression.
Yi, Tao, Qi, Li, Li, Ji et al. · Neural regeneration research · 2016 · DOI
Quick Summary
This study tested whether moxibustion, a traditional Chinese medicine technique using heat from burning herbs, could help rats with chronic fatigue syndrome. Researchers found that moxibustion reduced stress hormone levels and increased a protective protein in the brain called progranulin, which appeared to improve the rats' symptoms of fatigue and low mood.
Why It Matters
Understanding how complementary therapies might work in ME/CFS could expand treatment options and validate traditional medicine approaches that patients report finding helpful. This study identifies specific biological pathways—stress hormone dysregulation and neuroinflammation—that are relevant to ME/CFS pathophysiology and worth investigating further in human research.
Observed Findings
- Moxibustion decreased corticotropin-releasing hormone (CRH) mRNA expression in the hypothalamus of chronic fatigue syndrome rats.
- Moxibustion reduced plasma adrenocorticotropic hormone (ACTH) and corticosterone levels in treated animals.
- Moxibustion markedly increased progranulin mRNA and protein expression in the hippocampus.
- Behavioral testing showed improvement in symptoms of fatigue and depression in moxibustion-treated rats compared to untreated chronic fatigue syndrome controls.
Inferred Conclusions
- Moxibustion may relieve behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal (HPA) axis.
- Upregulation of hippocampal progranulin may contribute to symptom relief through neuroprotective mechanisms.
- Traditional acupuncture points (CV4 and ST36) appear to have measurable effects on neuroendocrine and neurobiological systems implicated in fatigue.
Remaining Questions
- Does progranulin upregulation directly cause the behavioral improvements, or is it a marker of other therapeutic mechanisms?
- How do the effects of moxibustion at these specific acupoints compare to moxibustion at other sites or sham treatment?
- Can these findings be replicated in human patients with ME/CFS, and would humans show similar HPA axis and progranulin changes?
What This Study Does Not Prove
This study does not prove that moxibustion is effective in humans with ME/CFS; animal models of fatigue do not necessarily translate to human disease. The findings show correlation between molecular changes and behavioral improvements in rats, but do not establish that progranulin upregulation is the direct cause of symptom relief. Results from one rat study cannot be generalized to human treatment effectiveness or safety without rigorous clinical trials.
Tags
Symptom:Fatigue
Biomarker:Gene ExpressionBlood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.4103/1673-5374.180746
- PMID
- 27212922
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →